Estimates Revisions Exact Sciences Corporation
Equities
EXAS
US30063P1057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.91 USD | -2.64% |
|
-2.72% | -7.62% |
| Jul. 09 | Tariff Drama, Minimal Market Reaction |  |
| Jul. 09 | Exact Sciences Says Its Oncodetect Test to Detect Colorectal Cancer Gets Medicare Coverage | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| - | - | |||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- EXAS Stock
- Consensus Exact Sciences Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
